Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating From Analysts at StockNews.com
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating From Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Monday. The firm set a "sell" rating on the stock.
Ayala Pharmaceuticals Price Performance
Ayala Pharmaceuticals stock opened at $1.55 on Monday. Ayala Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $10.80.
Get Ayala Pharmaceuticals alerts:Ayala Pharmaceuticals Company Profile
(Get Rating)
Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.
Featured Articles
- Get a free copy of the StockNews.com research report on Ayala Pharmaceuticals (ADXS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Monday. The firm set a "sell" rating on the stock.
StockNews.com的股票研究分析师假设对以下股票进行了报道 阿亚拉制药（纳斯达克股票代码：ADXS — 获取评级） 在周一发布的一份报告中。该公司对该股设定了 “卖出” 评级。
Ayala Pharmaceuticals Price Performance
阿亚拉制药的价格表现
Ayala Pharmaceuticals stock opened at $1.55 on Monday. Ayala Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $10.80.
周一，阿亚拉制药股开盘价为1.55美元。阿亚拉制药的52周低点为1.00美元，为52周的高点为10.80美元。
Ayala Pharmaceuticals Company Profile
阿亚拉制药公司简介
(Get Rating)
（获取评级）
Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.
Advaxis, Inc是一家生物技术公司，从事癌症免疫疗法的发现、开发和商业化。它管理的平台技术利用活的减毒单核细胞增生李斯特菌分泌抗原或辅助融合蛋白。该公司拥有四个处于不同临床和临床前开发阶段的特许经营权，即：人乳头瘤病毒相关癌症、前列腺癌、新抗原疗法和热点突变疗法。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on Ayala Pharmaceuticals (ADXS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don't Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
- 免费获取 StockNews.com 关于阿亚拉制药（ADXS）的研究报告的副本
- MarketBeat Week 回顾 — 3 月 13 日 — 3 月 17 日
- 这家具有巨大增长前景的小型科技公司已接近买入点
- 不要追高联邦快递，等着回调
- 防御性科技投资组合的3只股票
- 在这 3 头摇钱树身上挤出股息
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接收《阿亚拉制药日报》的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Ayala Pharmicals及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧